Hereditary nonpolyposis colorectal cancer (HNPCC) is the most common form of inherited colon cancer, accounting for about 9000 cases each year and affecting about 1 in 200 men and women.
1 It is characterized by an autosomal dominant mode of genetic transmission of susceptibility to colorectal cancer, a preponderance of early-onset colon cancers, a propensity toward proximal colon tumors, and frequent multiple primary tumors. Tumors integral to HNPCC include carcinoma of the endometrium, ovary, upper urologic tract, stomach, and small bowel. Molecular studies have identified 5 mismatch repair genes (
hMSH2,
hMLH1,
PMS1,
PMS2, and
hMSH6) that are responsible for most HNPCC cases.
2-5 Mutations in these genes confer a lifetime risk of colon cancer of approximately 80% to 85%.
6,7